The Effect of Neurofeedback on Eating Behaviour
Last updated on April 2022Recruitment
- Recruitment Status
- Unknown status
- Estimated Enrollment
- 120
Inclusion Criteria
- Willingness to be informed about chance findings of pathology and approval of the disclosure of this information to the general physician (see Informed Consent)
- Informed consent to study protocol
- Body Mass Index (BMI) between 25 and 40 kg/m2
- ...
- Willingness to be informed about chance findings of pathology and approval of the disclosure of this information to the general physician (see Informed Consent)
- Informed consent to study protocol
- Body Mass Index (BMI) between 25 and 40 kg/m2
- Healthy male and female subjects
- Age 18-65 years at start of the study
- Fulfilment of the criteria for blood donors according to the "Richtlinien zur Gewinnung von Blut und Blutbestandteilen und zur Anwendung von Blutprodukten", in particular Hb ≥ 135 g/l (8,37 mmol/l; Bundesärztekammer 2010)
Exclusion Criteria
- Lack of ability to give informed consent
- Insulin pump
- Operation less than three month ago
- ...
- Lack of ability to give informed consent
- Insulin pump
- Operation less than three month ago
- Intake of antidepressants / antipsychotics
- Intraport, etc.
- Pathological hearing ability or an increased sensitivity to loud noises
- Metallic implants (screws, plates from operations, etc.)
- Severe psychotic illness
- Acute illness or infection during the last 4 weeks
- Non-removable dental braces
- Heart pace-maker
- Current weight loss regimens
- Limited temperature perception and/or increased sensitivity to warming of the body
- Acupuncture needles
- Claustrophobia
- Moderate or severe head injury
- Artificial heart valve
- Metal splinters / grenade fragments
- Participation in other studies with blood withdrawals or blood donation in previous and subsequent 2 months
- Simultaneous participation in other studies
- Metal prosthesis
- Neurological disorder or injury
- In field strengths of over 1.0 T also: tattoos, eye lid-shadow
Summary
- Conditions
- Eating Behaviour
- Obesity
- Type
- Interventional
- Design
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Single (Participant)
- Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 65 years
- Gender
- Both males and females
Description
Primary objective: We want to investigate whether the training-induced up-regulation of the dorsal prefrontal cortex inhibits eating behaviour. Study design: A parallel design. Half of the participants will learn to up-regulate activity of the dorsolateral prefrontal cortex (dlPFC), while the other ...
Primary objective: We want to investigate whether the training-induced up-regulation of the dorsal prefrontal cortex inhibits eating behaviour. Study design: A parallel design. Half of the participants will learn to up-regulate activity of the dorsolateral prefrontal cortex (dlPFC), while the other participants will participate in sham-training sessions. Adherence to experimental conditions will be assigned randomly, based on the participants' enrolment in the study, balanced by gender and binge eating classification. Study population: 50 overweight and obese (BMI 25-40 kg/m2), but otherwise healthy individuals, 18-65 years old. Intervention: All participants will participate in a screening day, followed by one neurofeedback session day and a follow-up day. During the neurofeedback session, participants will undergo a 45 min real-time-fMRI-brain-computer-interface scan in order to learn to up-regulate dlPFC activation. Main study parameters/endpoints: The ability to up-regulate dlPFC activity. Respective effects on eating behaviour. Nature and extent of the burden and risks associated with participation: Participants will be scanned once (fMRI). Functional MRI is a safe and non-invasive technique.
Inclusion Criteria
- Willingness to be informed about chance findings of pathology and approval of the disclosure of this information to the general physician (see Informed Consent)
- Informed consent to study protocol
- Body Mass Index (BMI) between 25 and 40 kg/m2
- ...
- Willingness to be informed about chance findings of pathology and approval of the disclosure of this information to the general physician (see Informed Consent)
- Informed consent to study protocol
- Body Mass Index (BMI) between 25 and 40 kg/m2
- Healthy male and female subjects
- Age 18-65 years at start of the study
- Fulfilment of the criteria for blood donors according to the "Richtlinien zur Gewinnung von Blut und Blutbestandteilen und zur Anwendung von Blutprodukten", in particular Hb ≥ 135 g/l (8,37 mmol/l; Bundesärztekammer 2010)
Exclusion Criteria
- Lack of ability to give informed consent
- Insulin pump
- Operation less than three month ago
- ...
- Lack of ability to give informed consent
- Insulin pump
- Operation less than three month ago
- Intake of antidepressants / antipsychotics
- Intraport, etc.
- Pathological hearing ability or an increased sensitivity to loud noises
- Metallic implants (screws, plates from operations, etc.)
- Severe psychotic illness
- Acute illness or infection during the last 4 weeks
- Non-removable dental braces
- Heart pace-maker
- Current weight loss regimens
- Limited temperature perception and/or increased sensitivity to warming of the body
- Acupuncture needles
- Claustrophobia
- Moderate or severe head injury
- Artificial heart valve
- Metal splinters / grenade fragments
- Participation in other studies with blood withdrawals or blood donation in previous and subsequent 2 months
- Simultaneous participation in other studies
- Metal prosthesis
- Neurological disorder or injury
- In field strengths of over 1.0 T also: tattoos, eye lid-shadow
Tracking Information
- NCT #
- NCT02148770
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Manfred Hallschmid, PhD University Tuebingen
- Manfred Hallschmid, PhD University Tuebingen